NeuroTherm buys S&N interventional spine pain management biz
This article was originally published in The Gray Sheet
Executive SummaryNeuroTherm acquires Smith & Nephew's interventional spine pain management business, the firm announces April 7. The deal will "go a long way towards sustaining NeuroTherm's leading position in the interventional pain space," an estimated $5 billion global market, according to CEO Larry Hicks. Headquartered in Wilmington, Mass., NeuroTherm gains S&N's CDS Discography System, Spinecath and Acutherm catheters, and a line of radiofrequency devices. It also will be a distributor of the Trucath injection system. NeuroTherm's existing lineup includes RF devices and catheters for pain. The acquired product line "is highly complementary," the firm notes
You may also be interested in...
Can shaving ever be “friction free”? Not according to Procter & Gamble, which challenged in a complaint to the UK Advertising Standards Authority a claim made by a British cosmetics firm FFS that it provided a “friction free” shaving experience for women via its subscription razor service.
Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.